Total Payments
$17,346
2021 Payments
$66.08
Companies
14
Transactions
64
Payment Breakdown by Category
Consulting$9,808 (56.5%)
Food & Beverage$4,148 (23.9%)
Travel$3,289 (19.0%)
Education$101.00 (0.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $9,808 | 3 | 56.5% |
| Food and Beverage | $4,148 | 49 | 23.9% |
| Travel and Lodging | $3,289 | 10 | 19.0% |
| Education | $101.00 | 2 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. | $8,730 | 13 | $0 (2018) |
| Genentech USA, Inc. | $4,751 | 7 | $0 (2018) |
| Amgen Inc. | $760.82 | 8 | $0 (2019) |
| AbbVie Inc. | $663.51 | 5 | $0 (2020) |
| GENZYME CORPORATION | $579.91 | 7 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $477.32 | 5 | $0 (2020) |
| Lilly USA, LLC | $360.16 | 5 | $0 (2021) |
| Janssen Scientific Affairs, LLC | $307.36 | 5 | $0 (2019) |
| Celgene Corporation | $262.59 | 3 | $0 (2018) |
| Janssen Biotech, Inc. | $250.00 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $66.08 | 1 | Lilly USA, LLC ($66.08) |
| 2020 | $343.48 | 4 | Lilly USA, LLC ($105.00) |
| 2019 | $1,745 | 16 | AbbVie, Inc. ($604.65) |
| 2018 | $9,678 | 25 | Regeneron Pharmaceuticals, Inc. ($8,730) |
| 2017 | $5,513 | 18 | Genentech USA, Inc. ($4,651) |
All Payment Transactions
64 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/17/2021 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $66.08 | General |
| Category: Immunology | ||||||
| 03/10/2020 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $81.06 | General |
| Category: IMMUNOLOGY | ||||||
| 03/06/2020 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $58.86 | General |
| 02/18/2020 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $105.00 | General |
| Category: Immunology | ||||||
| 02/12/2020 | GENZYME CORPORATION | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $98.56 | General |
| Category: Immunology | ||||||
| 10/24/2019 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT | Food and Beverage | In-kind items and services | $94.50 | General |
| Category: Immunology | ||||||
| 10/17/2019 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $124.68 | General |
| Category: Bone Health | ||||||
| 10/11/2019 | Regeneron Healthcare Solutions, Inc. | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $115.20 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/26/2019 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $109.28 | General |
| 09/26/2019 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $14.55 | General |
| 07/18/2019 | Lilly USA, LLC | — | Education | In-kind items and services | $1.00 | General |
| 06/26/2019 | GENZYME CORPORATION | KEVZARA (Drug), RHEUMATOID ARTHRITIS DISEASE | Food and Beverage | In-kind items and services | $96.07 | General |
| Category: IMMUNOLOGY | ||||||
| 06/20/2019 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $80.82 | General |
| 06/06/2019 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $105.91 | General |
| Category: Bone Health | ||||||
| 05/22/2019 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $86.28 | General |
| Category: Bone Health | ||||||
| 05/22/2019 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $86.28 | General |
| 05/03/2019 | AbbVie, Inc. | Humira (Biological) | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| Category: Immunology | ||||||
| 04/11/2019 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $117.03 | General |
| Category: Inflammation | ||||||
| 04/02/2019 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $123.93 | General |
| Category: DERMATOLOGY | ||||||
| 02/26/2019 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $93.58 | General |
| Category: Immunology | ||||||
| 01/10/2019 | Janssen Scientific Affairs, LLC | — | Food and Beverage | In-kind items and services | $95.75 | General |
| 12/05/2018 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | Cash or cash equivalent | $85.01 | General |
| Category: DERMATOLOGY | ||||||
| 10/22/2018 | GENZYME CORPORATION | KEVZARA (Drug), RHEUMATOID ARTHRITIS DISEASE | Food and Beverage | In-kind items and services | $69.23 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $25.99 | General |
| Category: ONCOLOGY | ||||||
| 10/20/2018 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI ARIA, STELARA | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Immunology | ||||||
About Dr. Edward Lally, MD
Dr. Edward Lally, MD is a Rheumatology healthcare provider based in E. Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1770520090.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Edward Lally, MD has received a total of $17,346 in payments from pharmaceutical and medical device companies, with $66.08 received in 2021. These payments were reported across 64 transactions from 14 companies. The most common payment nature is "Consulting Fee" ($9,808).
Ad
Practice Information
- Specialty Rheumatology
- Location E. Providence, RI
- Active Since 06/02/2006
- Last Updated 10/12/2016
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1770520090
Products in Payments
- KEVZARA SARILUMAB INJECTION (Biological) $8,730
- Actemra (Biological) $4,651
- COSENTYX (Biological) $477.32
- KEVZARA (Drug) $438.82
- Humira (Biological) $400.00
- TALTZ (Drug) $359.16
- Otezla (Drug) $262.59
- KEVZARA (Biological) $213.76
- STELARA (Biological) $211.61
- EVENITY (Biological) $210.96
- REMICADE (Biological) $125.00
- SIMPONI ARIA (Biological) $125.00
- Enbrel (Biological) $117.03
- Prolia (Biological) $105.91
- Rituxan (Biological) $100.00
- RHEUMATOID ARTHRITIS DISEASE (Drug) $91.90
- OFEV (Drug) $25.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.